[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Dr. Martens Plc LSE:DOCS London Ordinary Share GB00BL6NGV24 ORD GBP0.01
  Price Change % Change Share Price Shares Traded Last Trade
  -4.60 -1.14% 399.80 1,432,764 16:35:23
Bid Price Offer Price High Price Low Price Open Price
398.60 399.40 404.40 389.60 404.40
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Retailers 773.00 70.90 3.60 111.1 3,998
Last Trade Time Trade Type Trade Size Trade Price Currency
17:58:18 O 3,101 397.45 GBX

Dr. Martens (DOCS) Latest News

More Dr. Martens News
Dr. Martens Investors    Dr. Martens Takeover Rumours

Dr. Martens (DOCS) Discussions and Chat

Dr. Martens Forums and Chat

Date Time Title Posts
17/9/202116:05Dr. Martens43
14/2/202116:55Dr Martens - just mucking about (please ignore)10

Add a New Thread

Dr. Martens (DOCS) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
17:15:24398.673,00011,960.10O
17:15:09397.586,00023,854.50O
17:08:21399.822,93611,738.72O
17:03:06397.42238945.86O
17:03:06400.396962,786.68O
View all Dr. Martens trades in real-time

Dr. Martens (DOCS) Top Chat Posts

DateSubject
30/11/2021
08:20
Dr. Martens Daily Update: Dr. Martens Plc is listed in the General Retailers sector of the London Stock Exchange with ticker DOCS. The last closing price for Dr. Martens was 404.40p.
Dr. Martens Plc has a 4 week average price of 355.60p and a 12 week average price of 355.60p.
The 1 year high share price is 521.60p while the 1 year low share price is currently 355.60p.
There are currently 1,000,000,100 shares in issue and the average daily traded volume is 778,871 shares. The market capitalisation of Dr. Martens Plc is £3,998,000,399.80.
24/5/2021
21:29
mj19: At a share price of 457p, the shares trade on a PE of 30 times 2022F earnings per share (EPS). This compares with global athleisure powerhouses Nike and Adidas on 34 times and 26 times, respectively.This is a punchy valuation from which it is very easy to construct a bear case. The sustainability of the current enthusiasm for the brand is a valid concern, but if management is only vaguely right about the future potential of the business then the shares could turn out to be a very good buy from here. It does not look like a business that has been fattened up for sale.
01/5/2021
08:55
mj19: Comparing with valuation multiples for 2022 for peers Canada Goose, Crocs, Deckers, Moncler, and VF Corp, this would imply fair value of 267-543p for the shares, Barclays said."We look for management to build a track record as a public company before arguing DOCS deserves to trade at the top of this range."Revenues and earnings per share are forecast by RBC to grow 14%-plus and 22%-plus out to 2025, while free cash flow "should improve broadly in line with earnings, whilst a progressive 25-35% dividend payout from 1H22 is helpful".On RBC's estimates, the shares trade at 35 times forecast 2021 earnings compared to a peer group at 30 times.
08/2/2021
14:23
davecrashandburns: I work in footwear (and have for 20 years) - that people have bought this IPO shocks me (even in the mad bubble world we find ourselves in). That the price has been bid even higher is the thing that beggars belief. I love the brand and know the product well. The quality has got poorer but that is not always relevant. The key thing for me is this brand becomes mega fashionable about every ten years. In those two or three years it is hot, everyone buys a pair. Then sales drop back and the fashion customers go on to something else. The brand is left with its core demographic of young people making a statement and poeple who buy it becuase it's practical and wears well. I would value the company at about 5-7 times recent earnings (becuase normally it sells much less) I would think of shorting it (never seen something so obvisously insane in a market I understand VERY well) but you never know how long it will take to fall - if there are enough believers to keep it up it could have a few years at this price.
03/2/2021
10:36
bookbroker: Called asset stripping, in this case investor stripping. I don’t care whether this has a prescence in 50 countries and be seen as a fashion brand, at the end of the day they make cheap footwear at a high price, and not that well-made at that. Hey-ho, let’s make it worth as much as any super brand, but we have gone beyond the pale here. It is difficult to see how they make this company much more profitable, that is why Permira have put it to the market.
29/1/2021
07:53
netcurtains: !FOLLOWFEED DOCS traders thread showing volume and RSI etc etc I just like to see volume etc
29/1/2021
07:36
bigbigdave: 29 January 2021 Dr. Martens plc Announcement of Offer Price Offer Price set at 370 pence per Share Following the intention to float announcement on 18 January 2021, Dr. Martens plc (the "Company" or "Dr. Martens"), today announces the successful pricing of its initial public offering (the "Offer") at 370 pence per Share (the "Offer Price"). Based on the Offer Price, Dr. Martens' market capitalisation will be approximately GBP3.7 billion at the commencement of conditional dealings on the main market of the London Stock Exchange. Kenny Wilson, CEO of Dr. Martens, said: "We have been delighted by the strong levels of interest, engagement and support from such a high quality selection of institutional investors. The successful transformation of Dr. Martens is a great story, and what is even more exciting is the huge potential ahead. We are proud to take our place as a London listed company, both delivering as a successful plc and more importantly continuing to grow our Brand around the world."
Dr. Martens share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
DOCS
Dr. Marten..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211130 19:20:06